Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitejouncetx.com
CategoryBioTech
Phone857-259-3840
Employees

Offices

Cambridge, USA
1030 Massachusetts Avenue
Cambridge, MA, 02138
USA

People

CTO
CBO
Vice President of Research
Director of Business Development and Operations
Interim CEO
Interim Chief Technology Officer

Funding

TOTAL $47M
FUNDING TOTAL $47M
Series A, 2/2013
Third Rock Ventures
$47M

Tags

Jounce Therapeutics

Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce’s proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patients’ quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.

Recent Milestones

Videos

Screenshots

Sources

  1. Jounce Therapeutics Raises $47M in Series A Financing from Third Rock Ventures (finsmes.com) [edit]
Edit This Page
Last Edited 11/25/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy